Elbonix 50 MG (Eltrombopag)

Posted 2025-08-14 07:03:52

Elbonix (Eltrombopag) 50 mg treats low platelet counts in adults with chronic immune thrombocytopenia (ITP) unresponsive to other therapies, helping reduce bruising and bleeding risks. Approved in 2012, it’s also used in chronic hepatitis C patients to maintain platelet levels during interferon-based treatment.

Effettua l'accesso per mettere mi piace, condividere e commentare!

Sponsorizzato

Altre informazioni

The Competitive Landscape of the Monk Fruit Sugar Industry

The Rise of Monk Fruit Sugar in the Sweetener Market In recent years, the global sweetener...

By 2024-05-27 13:10:44 0 2K

Health

Middle East and Africa Prostate Cancer Diagnostics Market Emerging Players May Yields New Opportunities 2029

The large-scale Middle East and Africa Prostate Cancer Diagnostics Market market report...

By 2023-08-21 07:35:47 0 3K

Technology

Unified Communication as a Service Market Size, Share [2032]

Unified Communication as a Service Market Overview Unified Communication as a Service (UCaaS) is...

By 2024-12-30 06:23:51 0 2K

Health and Wellness

Do Personality Traits Predict How We Get Along With Others? Are some personalities better suited for successful relationships than others? Reviewed by Ray Parker

KEY POINTS- Certain personality traits may help people get along better with others, but not...

By 2023-06-30 05:09:21 0 4K

Health

Veterinary Ultrasound Scanner Market by 2023 to 2033: Key Drivers and Opportunities

The global veterinary ultrasound scanner market is poised for significant growth, with forecasts...

By 2024-12-12 08:16:15 0 2K